NMR metabolomic signatures reveal predictive plasma metabolites associated with long-term risk of developing breast cancer
International Journal of Epidemiology Feb 09, 2018
Lecuyer L, et al. - Herein, the possible contribution of plasma untargeted metabolomic profiles, established from a simple blood draw from healthy women, to predict the risk of developing breast cancer within the following decade as well as to better understand the aetiology of this complex disease was investigated. Essentially, associations were apparent between baseline nuclear magnetic resonance (NMR) plasma metabolomic signatures and long-term breast cancer risk. In addition, findings offer interesting insights to better understand complex mechanisms involved in breast carcinogenesis and evoke plasma metabolic disorders favourable for carcinogenesis initiation. Additionally, the results may contribute to develop screening strategies for the detection of at-risk women for breast cancer well before symptoms appear.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries